Mindfulness-based Ecological Momentary Intervention for Smoking Cessation Among Cancer Survivors
Purpose
The purpose of the study is to develop a new quit-smoking treatment among individuals with a cancer diagnosis using a smartphone app.
Condition
- Smoking Cessation
Eligibility
- Eligible Ages
- Over 18 Years
- Eligible Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- ≥18 years old - smoked ≥1 cigarette per day (even one or two puffs) within the past 30 days - having been diagnosed with cancer - being motivated to quit in the next 30 days - having a valid home address and functioning phone number - being able to read, write, and speak English - having a smartphone that allows installation of the app - willingness to download the app
Exclusion Criteria
- being enrolled in a smoking cessation program - current use of smoking cessation medications - evidence of current psychosis - current/planning pregnancy or lactation
Study Design
- Phase
- N/A
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel Assignment
- Primary Purpose
- Prevention
- Masking
- None (Open Label)
Arm Groups
| Arm | Description | Assigned Intervention |
|---|---|---|
|
Experimental Mindfulness |
Participants will receive brief counseling, nicotine replacement therapy, and intervention content delivered via the app. |
|
|
Active Comparator Quitline |
Participants will be referred to Quitline to receive standard care for smoking cessation. |
|
Recruiting Locations
Institute for Nicotine & Tobacco Studies
New Brunswick, New Jersey 08901
New Brunswick, New Jersey 08901
More Details
- Status
- Recruiting
- Sponsor
- Rutgers, The State University of New Jersey
Study Contact
Rutgers IRB/Human Research Protection Program9739723608
irboffice@research.rutgers.edu
Detailed Description
The study aims to test the feasibility and acceptability of the smartphone app we developed in conjunction with face-to-face brief cessation counseling and nicotine replacement therapy in a two-arm randomized controlled trial.